This federal contract award was made by the Defense Logistics Agency's Medical Supply Chain (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $16,721.76 fixed-price delivery order is for the provision of 4566581818 - ARTHROCELL PLUS ALLOGRAFT, 2.5CC. The contract has an ultimate completion date of December 5, 2024. Arthrex, a for-profit Subchapter S Corporation headquartered in Naples, Florida, has been awarded this contract without any...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $7,700.88 fixed-price delivery order is for the supply of ARTHROCELL PLUS ALLOGRAFT, a 5.0cc biological product used in orthopedic procedures. The contract has an ultimate completion date of December 23, 2024. Arthrex Inc. is a for-profit Subchapter S Corporation headquartered in Naples,...
This federal contract award, valued at $4,291.10, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract is a Delivery Order for the supply of "ARTHROCELL PLUS ALLOGRAFT, 5.0CC", a specialized orthopedic product. The contract is a Fixed Price with Economic Price Adjustment, with a completion date of November 15, 2024. Arthrex Inc. is a for-profit...
The federal contract award is to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The award, identified as SPE2DH19D7000|SPE2D424F14W0, is for the delivery of ARTHROCELL PLUS ALLOGRAFT, 2.5CC to the Defense Logistics Agency (DLA), which operates under the U.S. Department of Defense. The contract is a Delivery Order with a fixed price and economic price adjustment, valued at $2,280.24, and has an ultimate completion date of August 22, 2024. Arthrex is a...
This is a federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures, headquartered in Naples, Florida. The contract, valued at $47,549.12, is a Delivery Order awarded by the Medical Supply Chain (an alternate name for the Defense Logistics Agency) to provide 4,566,564,519 units of ARTHROCELL, 5.0CC. The contract has a fixed price with economic price adjustment pricing type and a completion date of December 3, 2024. This award is not...
This federal contract award was made by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The $81,257.75 fixed-price delivery order contract is for the supply of ARTHROCELL PLUS ALLOGRAFT, 5.0CC and has an ultimate completion date of May 23, 2025. Arthrex Inc. is a for-profit Subchapter S Corporation headquartered in Naples, Florida. The company specializes in developing, manufacturing, and supplying...
This is a federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies, headquartered in Naples, Florida. The contract, valued at $38,313.86, is a Delivery Order awarded by the Defense Logistics Agency's Medical Supply Chain for the procurement of 4567966734 ! ARTHROCELL PLUS ALLOGRAFT, 2.5CC. The contract is a Fixed Price with Economic Price Adjustment type and does not have a set-aside designation. Arthrex holds a significant single-award...
This is a firm-fixed price delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Arthrex Inc., a for-profit Subchapter S Corporation based in Naples, Florida. The contract is valued at $21,418.35 and covers the delivery of ARTHROCELL PLUS ALLOGRAFT, a 5.0cc orthopedic product, with an ultimate completion date of May 7, 2024. This contract is not associated with a set-aside program. Arthrex Inc. is a global leader in minimally invasive...
This federal contract award was issued by the Medical Supply Chain of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $16,661.46 Delivery Order contract is for the supply of the "IMPL SYS, ALLOGRAFT GRAFTLINK CP 2" medical device, with a performance period ending on December 12, 2024. Arthrex, a for-profit Subchapter S Corporation headquartered in Naples, Florida, has a significant Indefinite Delivery...
This is a $34,282.18 fixed-price delivery order contract awarded by the Medical Supply Chain division of the Department of Defense to Arthrex Inc., a for-profit Subchapter S Corporation based in Naples, Florida. The contract is for the provision of ARTHROCELL PLUS ALLOGRAFT, a 5.0CC orthopedic product, with a period of performance ending on October 1, 2024. This award does not have a set-aside designation, indicating it was competed on the open market. Arthrex Inc. is a global leader in...